Kriya Therapeutics

4819 Emperor Blvd, Suite 400
United States


NextGen Class of 2021
Show jobs for this employer

About Kriya Therapeutics

Kriya is a next generation gene therapy company focused on expanding the field to new frontiers. It has built a fully-integrated technology enabled platform for rational vector design, analytical testing, and scalable manufacturing to design and develop gene therapies for diseases with well-understood underlying biology. The company’s proprietary computational platform, SIRVETM, supports its approach to de novo vector design, targeted sequence modification, and data analysis. Kriya believes that rationally engineered gene therapies can address a broad universe of diseases – and it is prepared and equipped to lead this new revolution in medicine.

15 articles with Kriya Therapeutics